Shopping Cart
- Remove All
- Your shopping cart is currently empty
CM-272 is a dual G9a/DNA methyltransferases (DNMTs) inhibitor.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $67 | In Stock | |
5 mg | $163 | In Stock | |
10 mg | $289 | In Stock | |
25 mg | $538 | In Stock | |
50 mg | $777 | In Stock | |
100 mg | $1,090 | In Stock | |
1 mL x 10 mM (in DMSO) | $173 | In Stock |
Description | CM-272 is a dual G9a/DNA methyltransferases (DNMTs) inhibitor. |
Targets&IC50 | DNMT1:382 nM, DNMT3B:1200 nM (IC50), G9a:8 nM, DNMT3A:85 nM, GLP:2 nM |
In vitro | CM-272, inhibits cell proliferation and promotes apoptosis, inducing interferon-stimulated genes and immunogenic cell death. CM-272 significantly prolongs survival of AML, ALL and DLBCL xenogeneic models. |
In vivo | CM-272 (2.5 mg/kg; intravenous injection; daily; for 28 days; female Rag2?/?γc?/? mice) treatment significantly prolongs survival of CEMO-1 cells xenogeneic models.Induced a statistically significant increase in overall survival (OS) in mice. |
Cell Research | Cell Line:CEMO-1, MV4-11 and OCI-Ly10 cell lines. Concentration:125 nM, 250 nM, 500 nM (CEMO-1 cells); 135 nM, 270 nM, 540 nM (MV4-11 cells); 100 nM, 400 nM, 1000 nM (OCI-Ly10 cells). Incubation Time:12 hours, 24 hours, 48 hours and 72?hours |
Animal Research | CM-272 (2.5 mg/kg; intravenous injection; daily; for 28 days; female Rag2?/?γc?/? mice) treatment significantly prolongs survival of CEMO-1 cells xenogeneic models. Animal Model:Female BALB/Ca-Rag2?/?γc?/? mice (6–8-week-old) with CEMO-1 cells. Dosage:2.5 mg/kg. Administration:Intravenous injection; daily; for 28 days |
Molecular Weight | 478.63 |
Formula | C28H38N4O3 |
Cas No. | 1846570-31-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 96 mg/mL (200.57 mM) Ethanol: 96 mg/mL (200.57 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.